Clínica de Marly Statistics
Total Valuation
BVC:MARLY has a market cap or net worth of COP 90.76 billion. The enterprise value is -134.02 billion.
Market Cap | 90.76B |
Enterprise Value | -134.02B |
Important Dates
The next estimated earnings date is Friday, August 15, 2025.
Earnings Date | Aug 15, 2025 |
Ex-Dividend Date | Aug 4, 2025 |
Share Statistics
BVC:MARLY has 10.68 million shares outstanding.
Current Share Class | 10.68M |
Shares Outstanding | 10.68M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 43.45% |
Owned by Institutions (%) | 2.47% |
Float | 3.89M |
Valuation Ratios
The trailing PE ratio is 1.01.
PE Ratio | 1.01 |
Forward PE | n/a |
PS Ratio | 0.21 |
PB Ratio | 0.14 |
P/TBV Ratio | 0.14 |
P/FCF Ratio | n/a |
P/OCF Ratio | 8.97 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.49 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 61.89 |
Financial Position
The company has a current ratio of 3.37, with a Debt / Equity ratio of 0.01.
Current Ratio | 3.37 |
Quick Ratio | 3.28 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.04 |
Debt / FCF | -1.94 |
Interest Coverage | 102.51 |
Financial Efficiency
Return on equity (ROE) is 15.14% and return on invested capital (ROIC) is 11.02%.
Return on Equity (ROE) | 15.14% |
Return on Assets (ROA) | 8.83% |
Return on Invested Capital (ROIC) | 11.02% |
Return on Capital Employed (ROCE) | 15.60% |
Revenue Per Employee | 506.94M |
Profits Per Employee | 107.93M |
Employee Count | 833 |
Asset Turnover | 0.56 |
Inventory Turnover | 42.02 |
Taxes
In the past 12 months, BVC:MARLY has paid 40.02 billion in taxes.
Income Tax | 40.02B |
Effective Tax Rate | 30.57% |
Stock Price Statistics
Beta (5Y) | -0.03 |
52-Week Price Change | n/a |
50-Day Moving Average | 8,500.00 |
200-Day Moving Average | 8,500.00 |
Relative Strength Index (RSI) | 100.00 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BVC:MARLY had revenue of COP 422.28 billion and earned 89.91 billion in profits.
Revenue | 422.28B |
Gross Profit | 160.11B |
Operating Income | 107.27B |
Pretax Income | 130.89B |
Net Income | 89.91B |
EBITDA | 112.44B |
EBIT | 107.27B |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 235.20 billion in cash and 4.20 billion in debt, giving a net cash position of 231.00 billion or 21,633.52 per share.
Cash & Cash Equivalents | 235.20B |
Total Debt | 4.20B |
Net Cash | 231.00B |
Net Cash Per Share | 21,633.52 |
Equity (Book Value) | 634.20B |
Book Value Per Share | n/a |
Working Capital | 253.42B |
Cash Flow
In the last 12 months, operating cash flow was 10.11 billion and capital expenditures -12.28 billion, giving a free cash flow of -2.17 billion.
Operating Cash Flow | 10.11B |
Capital Expenditures | -12.28B |
Free Cash Flow | -2.17B |
FCF Per Share | -202.79 |
Margins
Gross margin is 37.92%, with operating and profit margins of 25.40% and 21.29%.
Gross Margin | 37.92% |
Operating Margin | 25.40% |
Pretax Margin | 31.00% |
Profit Margin | 21.29% |
EBITDA Margin | 26.63% |
EBIT Margin | 25.40% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1,776.00, which amounts to a dividend yield of 20.89%.
Dividend Per Share | 1,776.00 |
Dividend Yield | 20.89% |
Dividend Growth (YoY) | 54.25% |
Years of Dividend Growth | 1 |
Payout Ratio | 14.74% |
Buyback Yield | n/a |
Shareholder Yield | 20.89% |
Earnings Yield | 99.06% |
FCF Yield | -2.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 17, 2003. It was a forward split with a ratio of 1.025.
Last Split Date | Mar 17, 2003 |
Split Type | Forward |
Split Ratio | 1.025 |
Scores
BVC:MARLY has an Altman Z-Score of 2.56 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.56 |
Piotroski F-Score | 5 |